4
Changes in Ownership
Pyxis Oncology, Inc. Filed Acc 0001209191-23-049366
President and CEO sold 27,917 shares at an average $2.27 ($63,301)
- President and CEO gave up 184,742 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sullivan Lara President and CEO | 2023-09-11 | Sale | −20,000 | $2.27 | $45,414 | 2,605,182 | D |
| Sullivan Lara President and CEO | 2023-09-12 | Sale | −4,917 | $2.25 | $11,071 | 2,600,265 | D |
| Sullivan Lara President and CEO | 2023-09-13 | Sale | −3,000 | $2.27 | $6,816 | 2,597,265 | D |
| Sullivan Lara President and CEO | 2023-09-13 | Shares withheld for taxes | −184,742 | $2.13 | $393,500 | 2,412,523 | D |
| Open-market sales · 27,917 sh · avg $2.27 · $63,301 | |||||||
Loading xslF345X05/doc4.xml…